Field Medical, founded with the mission to advance cardiac care, focuses on developing innovative technologies for cardiac ablation procedures. The company aims to enhance outcomes for physicians, cardiologists, and patients through its cutting-edge products. Field Medical's flagship technology, FieldForce™ Ventricular Pulsed Field Ablation, represents a pioneering approach in pulsed electric field ablation, positioning the company as a potential industry leader in this specialized market.
Notable figures associated with Field Medical include Dr. Steven Mickelsen, a key advocate for the future of pulsed field ablation. The company has achieved significant milestones, including the initiation of first-in-human trials for its groundbreaking FieldForce™ technology. Through these advancements, Field Medical is making a substantial impact on the cardiac care industry, striving to provide physicians with the tools they need and patients with the care they deserve.
